Partner & Patent Attorney

London Office Oxford Office

Life sciences

Telephone. +44(0) 207 776 5100
Mobile. +44(0) 794 706 5907
Email. [email protected]


From her first days in the patent profession, Claire has been involved with many of the major innovations in the life sciences’ field. These have spanned immunology-related therapeutics, RNA therapeutics, synthetic biology and genetic diagnostics, including applications of bioinformatics. This continues as a partner of both the specialist HGF CRISPR and microbiome IP teams.

Claire has extensive experience of opposition and appeal proceedings at the European Patent Office, including both defending and opposing high profile patents which have attracted much interest beyond patent professionals. This has included patents from the early days of recombinant antibodies through to controversial patents arising from gene discovery and more recently, much publicised patents for gene-editing technologies.

Claire also has much experience of handling patent portfolios demanding inter-disciplinary input including in the fields of bioinformatics and medical and diagnostic devices. This has included much in the application of high-throughput nucleic acid sequencing technologies such as non-invasive foetal testing and cancer diagnostics.

As one of the most experienced patent partners’ of the life science team, Claire has the reputation of being able to apply creative thinking to turn around the most difficult IP problems. She has been responsible for building the IP portfolios of a number of companies and continues to enjoy the challenge of advising on freedom-to-operate and IP strategy.


Patent Attorney

Chartered (UK)


MA(Oxon) Biochemistry with supplemental chemical pharmacology


PhD St George's Hospital Medical School


IAM Patent 1000 listed in 2021

Accompanying quotes: a " fearless warrior"; "Claire pays meticulous attention to detail and has superb technical and scientific knowledge; clients can concentrate on their own growth knowing their IP is in safe hands."

View recognition online


IAM Patent 1000 2022

View publication online

Getting your first filing right

View publication online

WIPR Publication 10 April 2019: Life Sciences: it pays to be wary over CRISPR

View publication online

LSIPR article June 2019: Russian Scientist pledges to make more CRISPR- edited babies

View publication online

LSIPR article March 2020: Broad Institute down (but not out) in the European Fight over CRISPR IP

View publication online

Regular provider of WIPR webinars on the CRISPR IP saga

Conferences: 2022

May 10th 2022

The HGF IP in Healthcare Conference 2022


Event details

March 23rd 2022

HGF webinar: Getting your first filing right


Event details

Conferences: 2020

March 3rd 2020

IP in Healthcare Conference 2020


Event details

Conferences: 2019

November 21st 2019

Life Sciences Patent Network Europe 2019


Event details

June 27th 2019

Update on the CRISPR IP Saga and lessons to be learnt - Basel


Event details

June 3rd 2019

2019 BIO International Convention - Philadelphia


Event details

April 25th 2019

Life Science Patent Network North America - Boston


Event details

March 14th 2019

IP in Healthcare Conference 2019 - London & Manchester


Event details

Related News

Food technology companies and investors - the value of IP landscape analysis

Case study – alt fat innovation Many companies and investors are aware of the importance of identifying and protecting their innovations, and in particular of the importance of obtaining patents …

Read article
Event - 29th September 2022

North East Automotive Expo 2022

HGF will be exhibiting at The North East Automotive Alliance’s flagship Expo on 29th September 2022. The event is an industry highlight for companies operating within the region’s automotive supply …

Event details
Event - 21st-22nd September 2022

Medical Technology Ireland 2022

Medical Technology Ireland Conference 2022 will be held on 21-22 September at the Galway Racecource. Medical Technology Ireland is a new high-profile National and International event attracting global suppliers to …

Event details

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.